The quantity field is empty. Please enter a quantity of 1 or more to add items to your cart.
Description
Overview
A highly potent and selective antagonist of adenosine A2A receptor (Ki = 600 pM). Does not affect the activity of other adenosine receptors in any significant manner (Ki = 287 nM; 5.0 µM, and > 10 µM for A1, A2B, and A3 receptors, respectively). Displays neuroprotective effects in cerebral ischaemia in rats, and shown to counteract Parkinsonian-like muscle rigidity in rats.
Ongini, E., et al. 1999. Naunyn Schmiedebergs Arch. Pharmacol.359, 7. Monopoli, A., et al. 1998. Neuroport.9, 3955. Zocchi, C., et al. 1996. J. Pharmacol. Exp. Ther.276, 398. Popoli, P., et al. 2000. Neuropsychopharmacology.22, 522.
Product Information
CAS number
160098-96-4
Form
Off-white solid
Hill Formula
C₁₈H₁₅N₇O
Chemical formula
C₁₈H₁₅N₇O
Reversible
Y
Structure formula Image
Applications
Biological Information
Primary Target
A2A Receptor
Primary Target K<sub>i</sub>
600 pM
Purity
≥99% by HPLC
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code
Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
Toxicity
Standard Handling
Storage
+2°C to +8°C
Protect from Light
Protect from light
Do not freeze
Ok to freeze
Special Instructions
Following reconstitution, aliquot and freeze (-20°C. Stock solutions are stable for up to 3 months at -20°C.
Packaging Information
Packaged under inert gas
Packaged under inert gas
Transport Information
Supplemental Information
Specifications
Documentation
Certificates of Analysis
Title
Lot Number
119150
References
Reference overview
Ongini, E., et al. 1999. Naunyn Schmiedebergs Arch. Pharmacol.359, 7. Monopoli, A., et al. 1998. Neuroport.9, 3955. Zocchi, C., et al. 1996. J. Pharmacol. Exp. Ther.276, 398. Popoli, P., et al. 2000. Neuropsychopharmacology.22, 522.
Data Sheet
Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.
A highly potent and selective antagonist of adenosine A2A receptor (Ki = 600 pM). Does not affect the activity of other adenosine receptors in any significant manner (Ki = 287 nM; 5.0 µM, and > 10 µM for A1, A2B, and A3 receptors, respectively). Displays neuroprotective effects in cerebral ischaemia in rats, and shown to counteract Parkinsonian-like muscle rigidity in rats.
Form
Off-white solid
Intert gas (Yes/No)
Packaged under inert gas
CAS number
160098-96-4
Chemical formula
C₁₈H₁₅N₇O
Structure formula
Purity
≥99% by HPLC
Solubility
100 mM in DMSO
Storage
+2°C to +8°C Protect from light
Do Not Freeze
Ok to freeze
Special Instructions
Following reconstitution, aliquot and freeze (-20°C. Stock solutions are stable for up to 3 months at -20°C.
Toxicity
Standard Handling
References
Ongini, E., et al. 1999. Naunyn Schmiedebergs Arch. Pharmacol.359, 7. Monopoli, A., et al. 1998. Neuroport.9, 3955. Zocchi, C., et al. 1996. J. Pharmacol. Exp. Ther.276, 398. Popoli, P., et al. 2000. Neuropsychopharmacology.22, 522.